# Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

> **NCT04197921** · NA · RECRUITING · sponsor: **InSightec** · enrollment: 29 (estimated)

## Conditions studied

- Opioid-use Disorder
- Substance Use Disorders

## Interventions

- **DEVICE:** Exablate Model 4000 Type 2.0/2.1

## Key facts

- **NCT ID:** NCT04197921
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04197921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04197921, "Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04197921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*